We know what it's like to be an optometry student trying to prepare for boards in the midst of a hectic class and clinic schedule. The KMK founders are overwhelmed with appreciation for the trust Optometry students put in our company.

Dr. Kyle Cheatham

Dr. Kyle Cheatham, FAAO, DIP ABO
Co-Founder & CEO

Kyle graduated from Centre College (KY) with a B.S. in Biology and completed optometry school at Indiana University School of Optometry before accepting a prestigious residency at the Kansas City VA Hospital. Dr. Cheatham practices at Vision Specialists, a group practice in Omaha, Nebraska. He serves as an adjunct faculty member of six schools and colleges of optometry teaching optometric interns at Heartland Eye Consultants. Dr. Cheatham also provides consultative care within the ophthalmology department at Creighton University Medical Center. In August 2011, Dr. Cheatham became a Diplomate of the American Board of Optometry. He is also president of the Fellowship of Christian Optometrists.

Melissa Cheatham, PA-C
Co-Founder & CPO

Melissa graduated from the University of Nebraska, Lincoln, with a Bachelor of Science degree in Communication Studies before receiving her Master’s in Physician’s Assistant Studies from University of Nebraska Medical Center. She has clinical experience in family practice and obstetrics and gynecology and now practices as a board certified physician assistant in cardiology with the Bryan Heart Institute in Lincoln, NE.

Melissa Cheatham

Kevin Wood, PhD
Co-Founder & CTO

Kevin graduated from Centre College (KY) with a B.S. in Chemical Physics before completing an M.S. in Biology and a double Ph.D. in both Theoretical Physics and Physical Chemistry at the University of California, San Diego (UCSD). He then served as a postdoctoral research fellow in the Department of Chemistry and, subsequently, in the Department of Molecular and Cellular Biology at Harvard University. Kevin is currently an Assistant Professor of Biophysics and Physics at the University of Michigan. His research group leverages theoretical tools from statistical physics to study population dynamics and the evolution of drug resistance in microbial infections and human cancers.